Universal Biosensors

Universal Biosensors company information, Employees & Contact Information

Universal Biosensors Inc (UBI) is a global biosensor company and a world leader in electrochemical cell technology. UBI’s ambition is to utilize its patented biosensor technology to develop a diverse range of biosensor test strips used in our hand-held portable analyzers; for cost effective, effortless, and accurate detection of analytes of interest, within many industries including human health, animal health, environmental, and agriculture. UBI is a USA Delaware company listed on the Australian Securities Exchange (ASX:UBI) and operates from its head office, manufacturing facility, and research laboratory in Melbourne, Victoria, Australia. In 2021, UBI successfully launched its unique handheld wine analyzer called Sentia™ with an initial test to measure free SO2 , and subsequently in 2022, tests for monitoring malic acid and glucose throughout the wine production process (more tests in the pipeline are due for release in late 2022). In 2022, UBI launched Xprecia Prime™ in the EU and UK, the next-generation blood coagulation analyzer which replaces Xprecia Stride™. Xprecia Prime™ is due for launch in the US in 2023. UBI is due to launch Petrackr™ in late 2022/early 2023, a veterinary blood glucometer to monitor diabetes in cats and dogs. These products will complement UBI’s existing Canadian blood testing laboratory Hemostasis Reference Lab (HRL).

Company Details

Employees
95
Founded
-
Address
1 Corporate Ave, Rowville,australia
Phone
61 3 9213 9000
Email
in****@****ors.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Melbourne, Vic
Looking for a particular Universal Biosensors employee's phone or email?

Universal Biosensors Questions

News

Aussie bio tech manufacturer folds amid $3.5m debts - Herald Sun

Aussie bio tech manufacturer folds amid $3.5m debts Herald Sun

We Think Universal Biosensors (ASX:UBI) Needs To Drive Business Growth Carefully - simplywall.st

We Think Universal Biosensors (ASX:UBI) Needs To Drive Business Growth Carefully simplywall.st

Warfarin and PT-INR testing: an interview with Paul Wright, CEO, Universal Biosensors - News-Medical

Warfarin and PT-INR testing: an interview with Paul Wright, CEO, Universal Biosensors News-Medical

Universal Biosensors (ASX:UBI) signs deal on 30-sec Covid-19 test - Finance News Network

Universal Biosensors (ASX:UBI) signs deal on 30-sec Covid-19 test Finance News Network

Top Universal Biosensors Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant